Who owns SCADDEN DAVID?

No ownership or control links for SCADDEN DAVID are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is SCADDEN DAVID's risk level?

WhiteIntel flags SCADDEN DAVID as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does SCADDEN DAVID appear across sources?

SCADDEN DAVID is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

SCADDEN DAVID

Name: SCADDEN DAVID — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, SCADDEN DAVID, Company, US

SCADDEN DAVID — US company (sec:0001707715). 4 holdings. Every claim linked to its source.

SEC 0001707715CompanyUS

Ownership graph Export .md

JSON / MCPsample

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

SCADDEN DAVID
- Editas Medicine, Inc.· director· via SEC EDGAR
- AGIOS PHARMACEUTICALS, INC.· director· via SEC EDGAR
- Carisma Therapeutics Inc.· director· via SEC EDGAR
- Dianthus Therapeutics, Inc. /DE/· director· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for SCADDEN DAVID — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of SCADDEN DAVID is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on SCADDEN DAVID is behind a paywall — everything we hold on this subject is already on this page.

/02

People & control

4 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
AGIOS PHARMACEUTICALS, INC.
Also holds roles at 61 other companies
- Viswanadhan Krishnanofficer
- Burns James Williamofficer
- Jones Ceciliaofficer
●
Carisma Therapeutics Inc.
Also holds roles at 70 other companies
- Klichinsky Michaelofficer
- Kelly Stevenofficer
- McAndrew Natalieofficer
●
Dianthus Therapeutics, Inc. /DE/
Also holds roles at 61 other companies
- KANGO SUJAYdirector
- CARR EDWARDofficer
- Veness Adam Mofficer
●
Editas Medicine, Inc.
Also holds roles at 89 other companies
- Lucera Erickofficer
- O'Neill Gilmore Neilofficer
- Burkly Lindaofficer

4 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns SCADDEN DAVID?: No ownership or control links for SCADDEN DAVID are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is SCADDEN DAVID's risk level?: WhiteIntel flags SCADDEN DAVID as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does SCADDEN DAVID appear across sources?: SCADDEN DAVID is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on SCADDEN DAVID. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…